$116,817,868
to UNIVERSITY OF CALIFORNIA, LOS ANGELES
LABORATORY CENTER, AIDS CLINICAL TRIALS GROUP (ACTG); LC 2 / 3
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds UCLA's laboratory center for the AIDS Clinical Trials Group to conduct HIV/AIDS research and clinical trials.
ACTG is a critical NIH network for testing HIV treatments and vaccines; this supports U.S. leadership in infectious disease research.
Drives demand for laboratory equipment, reagents, and clinical trial infrastructure from biotech suppliers.
HIV/AIDS research is a global health priority; U.S. dominance in clinical trial networks strengthens soft power and scientific leadership.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002201.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UM1AI106701_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.